Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 Study Group. Ison MG, et al. Among authors: descamps d. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. Clin Infect Dis. 2024. PMID: 38253338 Free PMC article. Clinical Trial.
Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted RSV Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled Trial.
Chandler R, Montenegro N, Llorach C, Aguirre LN, Germain S, Kuriyakose SO, Lambert A, Descamps D, Olivier A, Hulstrøm V. Chandler R, et al. Among authors: descamps d. Clin Infect Dis. 2024 Jan 8:ciad786. doi: 10.1093/cid/ciad786. Online ahead of print. Clin Infect Dis. 2024. PMID: 38189778
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Thiébaut R, Charpentier C, Damond F, Taieb A, Antoine R, Capeau J, Chêne G, Collin G, Matheron S, Descamps D, Brun-Vézinet F; French ANRS HIV-2 CO5 Cohort. Thiébaut R, et al. Among authors: descamps d. Clin Infect Dis. 2012 Nov 15;55(10):1417-25. doi: 10.1093/cid/cis708. Epub 2012 Aug 20. Clin Infect Dis. 2012. PMID: 22911639
Floquet-Bloch valleytronics.
Fragkos S, Fabre B, Tkach O, Petit S, Descamps D, Schönhense G, Mairesse Y, Schüler M, Beaulieu S. Fragkos S, et al. Among authors: descamps d. Nat Commun. 2025 Jul 1;16(1):5799. doi: 10.1038/s41467-025-61076-7. Nat Commun. 2025. PMID: 40593831 Free PMC article.
Combined screening of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in an emergency department: The URDEPTRIO cross-sectional study.
Wong C, Le Hingrat Q, Salipante F, Mackiewicz V, Damond F, Larrouy L, Choquet C, Pospai D, Champenois K, Descamps D, Leblanc J, Loubet P, Casalino E, Ghosn J, Bouzid D. Wong C, et al. Among authors: descamps d. Acad Emerg Med. 2025 May 14. doi: 10.1111/acem.70060. Online ahead of print. Acad Emerg Med. 2025. PMID: 40369975 No abstract available.
SARS-CoV-2 lineage-dependent temporal phylogenetic distribution and viral load in immunocompromised and immunocompetent individuals.
Zafilaza K, Fauchois A, Leducq V, Coppée R, Guilbaud R, Yusti AF, Todesco E, Bridier-Nahmias A, Hingrat QL, Choquet S, Cacoub P, Amoura Z, Barrou B, Pourcher V, Spano JP, Louet M, Kramer L, Goulenok T, Salpin M, Daugas E, Dorent R, Ottaviani S, Zalcman G, Ghosn J, Charpentier C, Descamps D, Marcelin AG, Calvez V, Ferre VM, Marot S, Soulie C. Zafilaza K, et al. Among authors: descamps d. Virol J. 2025 Apr 25;22(1):118. doi: 10.1186/s12985-025-02711-z. Virol J. 2025. PMID: 40281619 Free PMC article.
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Cuadripani S, Deraedt Q, Dezutter N, Gerard C, Fissette L, Xavier S, David MP, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 study group. Ison MG, et al. Among authors: descamps d. Lancet Respir Med. 2025 Jun;13(6):517-529. doi: 10.1016/S2213-2600(25)00048-7. Epub 2025 Apr 14. Lancet Respir Med. 2025. PMID: 40245915 Clinical Trial.
663 results